Dow Up 0.91% Nasdaq Up 1.69%

MEI Pharma, Inc. (MEIP)

-NasdaqCM
7.99 0.04(0.50%)
Prev Close:7.95
Open:N/A
Bid:7.97 x 200
Ask:8.00 x 400
1y Target Est:15.80
Beta:-1.45
Next Earnings Date:N/A
Day's Range:7.95 - 8.09
52wk Range:5.51 - 13.98
Volume:N/A
Avg Vol (3m):65,388
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MEIPUp 0.50%N/A
AZNN/A
SNYN/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-1.46
Quarterly EPS Est (Sep-14) :-0.38
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MEI Pharma, Inc., an oncology company, focuses on the clinical development of novel therapies for the treatment of cancer. The company’s lead drug candidate is Pracinostat, an orally available histone deacetylase inhibitor, which is in Phase ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback